Ferozsons Laboratories Limited

Investor Information

Financial Highlights

Figures as of 30 June 2026

PKR 9.46 B

Revenue

PKR 632 M

Net Profit

PKR 7.16

EPS

PKR 12.62 B

Market Cap

PKR 24,994,950

Free Float of Shares

19.96 Times

PE Ratio

N/A

Dividend Payout Ratio

PKR 59.93 per share

Breakup Value of Shares

Reports & Filings

Free Float – BF Bio Summary Report

2026

Download

Quarterly Report – September 30, 2026 (2027-Q1)

2026

Download

AGM Voting Results

2026

Download

Annual Report 2026

2026

Download

Proxy Form

2026

Download

Notice of Annual General Meeting-English

2026

Download

Notice of Annual General Meeting-Urdu

2026

Download

Annual Report 2025

2025

Download

Annual Report 2024

2024

Download

Corporate Governance

Bf Biosciences Ltd. is committed to the highest standards of corporate governance. Our Board of Directors provides strategic oversight and ensures accountability to shareholders and stakeholders. For more details, visit our Board of Directors page.